rhTPO combined with chemotherapy and G-CSF for autologous peripheral blood stem cells in patients with refractory/relapsed non-Hodgkin’s lymphoma
Jun Zhu,1 Si-Guo Hao,2 Jiong Hu,3 Jing-Li Zhuang,4 Chun Wang,1 Hai-Tao Bai1 1Department of Haematology, Shanghai General Hospital, Shanghai 200080, People’s Republic of China; 2Department of Haematology, Shanghai Jiaotong University Affiliated Xinhua Hospital, Shanghai 200092, People&r...
Main Authors: | Zhu J, Hao SG, Hu J, Zhuang JL, Wang C, Bai HT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/rhtpo-combined-with-chemotherapy-and-g-csf-for-autologous-peripheral-b-peer-reviewed-article-CMAR |
Similar Items
-
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study
by: Xiaofan Liu, et al.
Published: (2023-12-01) -
rhTPO Ameliorates Radiation-Induced Long-Term Hematopoietic Stem Cell Injury in Mice
by: Hao Luan, et al.
Published: (2023-02-01) -
A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
by: Qiuhua Zhu, et al.
Published: (2021-08-01) -
Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research
by: Fa-Min Gong, et al.
Published: (2024-01-01) -
The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial)
by: Zhigang Zhou, et al.
Published: (2019-09-01)